Companies

Shire chief optimistic on 2014

Shire, the London-listed pharmaceuticals group, has been rapidly growing and its rating rising. In this week's View from the Top, chief executive Flemming Ornskov tells Andrew Jack, the FT's pharmaceuticals correspondent, that he is optimistic about an economic recovery in Europe.